新生儿卡萨巴赫-梅里特现象的西罗利木斯单疗法;案例报告
Shoji Nakamura1, Michio Ozeki1, Daichi Hayashi1
1Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
International journal of surgery case reports
|March 22, 2024
概括
低剂量西洛斯有效地治疗了新生儿的卡萨巴赫-梅里特现象 (KMP),显示瘤减少和改善出血. 这表明,对于患有这种罕见血管瘤的婴儿来说,一种潜在的更安全的单一治疗方法.
科学领域:
- 儿科瘤学 儿科瘤学
- 血管异常 血管异常
- 药理学 药理学是指药理学的学科.
背景情况:
- 卡萨巴赫-梅里特现象 (KMP) 是一种罕见的血管瘤并发症,导致血小板缺血和凝血病.
- 现有的KMP治疗方法通常涉及组合疗法或更高剂量的药物,对新生儿构成挑战.
研究的目的:
- 报告新生儿使用低剂量西洛斯单疗法与KMP的新生儿的新用途.
- 评估这种方法在不成熟的代谢系统中的有效性和安全性.
主要方法:
- 一名被诊断患有KMP的新生儿每天接受低剂量西洛 (0.06毫克/天).
- 治疗结果包括瘤大小,出血状态和副作用在12个月内进行了监测.
主要成果:
- 单独治疗西罗利斯导致显著的质量减轻和改善出血.
- 瘤在12个月后仍然稳定,没有观察到副作用.
- 通过比通常报告的剂量更低的剂量获得了有利的结果.
结论:
- 低剂量西洛斯单疗可以有效治疗新生儿的KMP.
- 这种方法可能提供了一个更安全的替代方案,考虑到新生儿的代谢不成熟.
- 需要进一步的研究来确定儿科KMP治疗的最佳剂量和最低度.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414


